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Abstract 
Acetylcholine (Ach) has a fundamental role in cortical activation. The activation of 
the hippocampus, a cortex implicated in cognitive and sensorimotor functions, is 
characterized by an increase in power and frequency of oscillations in the theta (4-10 Hz) and 
gamma (30-100 Hz) frequency range. We studied hippocampal activation in two mutant 
mouse lines with deficiency in cholinergic functionality: VAChT KDHET (HET), and 
VAChTNkx2.1-Cre-flox/flox (KO). We hypothesized that the mutant mice, relative to wild-type 
(WT) mice, will manifest abnormal theta and gamma oscillations during different behaviors, 
and in response to muscarinic cholinergic antagonist scopolamine hydrochloride and to the 
NMDA receptor glutamatergic antagonist CPP. Local field potentials (LFPs) were recorded 
from CA1 stratum radiatum in behaving WT and mutant mice before and after injection of 
drugs. Immobile theta power decreased in the order of WT, HET, and KO. Injection of 
scopolamine abolished the awake-immobility theta in WT and KO mice, but a theta peak 
remained in the HET mutant mice. Injection of CPP abolished the awake-immobility theta in 
HET mice but not in WT and KO mice. Our data suggests that acetylcholine is critical for 
immobile theta power. The presence of a scopolamine-resistant and CPP-sensitive theta 
rhythm during awake-immobility in HET mice is a novel finding, since immobility-
associated theta rhythm was found to be scopolamine (or atropine) sensitive in WT mice and 
other laboratory animals. The compensatory changes that activate a scopolamine-resistant, 
presumably non-cholinergic, theta rhythm during immobility in HET mice remain to be 
identified. 
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1 Introduction 
1.1   Hippocampus 
 The hippocampus is part of the limbic system located in the medial temporal lobe 
of the human brain and plays important roles in the consolidation of information 
from short-term memory to long-term memory and in spatial navigation.  
1.1.1   Anatomy and circuitry of hippocampus 
 The hippocampus is one of the most studied brain areas in part due to its unique 
anatomy. The hippocampus in humans has been divided into six segments: dentate gyrus, 
cornu amonis (CA1-4) and the subiculum (Amaral and Witter, 1989). In rodents, CA4 is 
referred to as dentate hilus (Knowles, 1992). Hippocampal neurons and their projections 
have been organized in four layers. Stratum oriens is the most superficial layer followed 
by stratum pyramidale, stratum radiatum, and stratum lacunosum-moleculare (Amaral 
and Witter, 1989). 
 Pyramidal cells and granule cells are the two redundant cells found within the 
hippocampus. Pyramidal cells are located in cornu amonis regions (CA1, CA2, and 
CA3). Granule cells are found in the dentate gyrus, with their cell bodies located within 
stratum granulosum and their single dendritic arbour projecting to the molecular layer 
(Knowles, 1992). Dentate gyrus receives inputs from entorhinal cortex via the perforant 
pathway (Amaral and Witter, 1989; Anderson et al., 1971). Axons of the granule cells 
form the mossy fibers and innervate the proximal dendrites of the CA3 pyramidal cells in 
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stratum lucidum. Triangular shaped cell bodies of the CA1 pyramidal cells are located in 
the stratum pyramidale (Knowles, 1992). Basal and apical dendrites of the CA1 
pyramidal cells are located in the stratum oriens and stratum radiatum respectively. 
Schaffer collaterals (axons of the CA3 pyramidal cells) innervate both basal and apical 
dentrites of CA1 pyramidal cells via commissural and associational paths (Buzaki and 
Eidelberg, 1992). Both CA1 and CA3 regions of hippocampus also receive inputs from 
enthornial cortex (Amaral and Witter, 1989). Axons of the CA1 pyramidal cells terminate 
at subiculum and enthornial cortex.     
1.1.2   Interneurons 
 More than 20 types of interneurons have been classified that mostly use γ–
aminobutyric acid (GABA) as a neurotransmitter (Freund and Buzsaki, 1996; Benes and 
Berretta, 2001; Klausberger and Somogyi, 2008). The four main types of interneurons are 
bistratified cells, basket cells, chandelier cells, and oriens–lacunosum moleculare (O-LM) 
interneurons. Bistratified cells innervate both apical and basal dendritic branches of the 
pyramidal cells (Benes and Berretta, 2001). Bistratified interneurons receive input from 
CA3 and may participate in generation of CA3-driven gamma oscillation (Tukker et al., 
2007). Basket cells predominantly project to the cell body of pyramidal cells (Benes and 
Berretta, 2001). Basket cells burst at theta frequency (4-10Hz), with gamma frequency 
(30-100Hz) firing occurring within the bursts (Penttonen et al., 1998). Chandelier cells 
(also known as axo-axonic cells) form axo-axonic synapses with the initial segment of 
axons and regulate their action potential generation (Benes and Berretta, 2001). The 
oriens–lacunosum moleculare (O-LM) interneurons target the apical dendritic tuft aligned 
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with the entorhinal cortical input (Klausberger and Somogyi, 2008). Firing rate of 
interneurons may change with the behavior of an animal (Ranck, 1973).  
1.2   Acetylcholine 
Acetylcholine (ACh) in the nervous system has key functions in life, as it 
regulates multiple central and peripheral nervous system outputs. Acetylcholine is 
synthesized in the cytoplasm from acetyl-coenzyme A (derived from pyruvate generated 
in glycolysis within the mitochondria) and choline (Dobransky and Rylett, 2005). The 
reaction of choline with acetyl-CoA is catalyzed by an enzyme named choline 
acetyltransferase (ChAT) (Dobransky and Rylett, 2005). Synthesized ACh gets stored 
within the vesicles via a protein named vesicular acetylcholine transporter (VAChT). 
Upon arrival of action potentials, ACh is released into the synaptic cleft by exocytosis 
and then it gets degraded via a hydrolytic enzyme named actetylcholinesterase (AChE).  
1.2.1   Cholinergic receptors 
Muscarinic and nicotinic receptors are the two types of receptors classified for 
ACh. Muscarinic receptors are G-protein coupled receptors, and are divided into five 
subtypes (M1-M5). A broad range of muscarinic acetylcholine receptors (mAChRs) are 
expressed within the hippocampus, with M1, M3 and M5 receptors being mainly 
expressed postsynaptically on the pyramidal and granular cells and M2 and M4 receptors 
on the interneurons (Levey et al., 1995). M2
 
receptors also exist presynaptically on the 
cholinergic neurons projecting from medial septum to the hippocampus and play an auto-
regulatory role (Rouse et al., 1999). Activation of mAChRs in the hippocampus 
modulates the activity of multiple ligand-gated receptors including N-methyl-D-aspartate 
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(NMDA) glutamatergic receptors of the pyramidal cells (Markram and Segal, 1990). In 
addition, activation of mAChRs directly excites GABAergic interneurons. At the same 
time, it has a depressant effect on the synaptic release of GABA (Cobb and Davis, 2005). 
Nicotinic acetylcholine receptors (nAChRs) are made up of a pentametric combination of 
α (α2-α10) and ß (ß2-ß4) subunits. In particular, α7 nAChR subtype is highly expressed 
in both glutamatergic and GABAergic axon terminals and postsynaptic sites (Fabian-Fine 
et al., 2001). 
1.2.2   Acetylcholine and long term potentiation 
Long term potentiation (LTP) in the hippocampus is proposed to model a 
neuronal mechanism of learning and memory formation (Bliss and Collingridge, 1993). 
There is evidence that enhancement of septohippocampal cholinergic activity in behaving 
mice via stimulation enhances long term potentiation (Galey et al., 1994). The level of 
acetylcholine released from terminals varies based on the behavior of the animal (Dudar 
et al., 1979). In behaving rats, release of ACh is highest during walking and rapid eye 
movement (REM) sleep (Dudar et al., 1979). While the animal is alert-immobile, release 
of ACh reduces and the least amount of ACh is released during slow wave sleep (Dudar 
et al., 1979). Hippocampal LTP was facilitated when induced during walking, as opposed 
to when induced in the absence of theta (i.e. immobility). In addition, systemic 
scopolamine or 192 IgG-saporin septal lesions or specific M1 receptor antagonist 
pirenzepine attenuated LTP induced during walking without affecting LTP induced 
during immobility (Leung et al., 2003).  
Ji et al. (2001) reported that activation of presynaptic α7 nAChRs leads to an 
enhancement of glutamate release which increases the possibility of inducing LTP. On 
5 
 
the other hand, activation of α7 nAChRs on hippocampal interneurons can block LTP in 
the pyramidal cells (Ji et al., 2001).  Activation of septo-hippocapal cholinergic neurons 
via optogenetics or electrical stimulation induced different types of hippocampal 
Schaeffer collateral to CA1 synaptic plasticity (Gu and Yekel, 2011). Such plasticity 
depended on the timing of cholinergic input relative to the Schaeffer collateral input (Gu 
and Yekel, 2011). An α7 nAChR-dependent LTP was induced when the cholinergic input 
was activated 100 or 10 msec prior to Schaeffer collateral stimulation while the 
cholinergic stimulation delayed until 10 msec after the Schaeffer collateral stimulation 
induced a mAChR-dependent LTP was induced (Gu and Yekel, 2011). 
1.2.3   Alzheimer’s disease and the cholinergic neurons 
Alzheimer’s disease (AD) is an age-dependent neurodegenerative disorder 
characterized by progressive dementia (Chen et al., 2011). Alzheimer’s disease can be 
classified into three stages: 1) an early stage characterized by an inability to remember 
novel information where the initial encoding of that information is affected but not the 
retrieval of previously learned information; 2) a middle stage where deficits in semantic 
memory, working memory, spatial orientation, and attention are especially observed; and 
3) a late stage (or dementia) characterized by a global intellectual breakdown associated 
with changes in personality and behavior (Bontempi et al., 2001).  
It has been hypothesized that cholinergic dysfunction is a major cause for the 
cognitive deficit in AD (Bartus et al., 1982).  Synthesis of ACh via choline 
acetyltransferase has been found to be decreased in the AD brain (Fisher, 2008). In 
addition, presynaptic cholinergic axonal loss can be identified by reduction of vesicular 
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acetylcholine transporter (Chen et al., 2011). Degeneration of cholinergic neurons in the 
basal forebrain that project to the hippocampus and cerebral cortex is evident in AD 
(Fisher, 2008). Using magnetic resonance imaging (MRI) and voxel-based morphometry 
(VBM). Teipel et al. (2005) found a positive correlation between stages of AD and 
reduction of cholinergic neurons of basal forebrain. This positive correlation may be due 
to the interaction between amyloid ß accumulation and cholinergic dysfunction (Schliebs 
et al., 2006). The most common prescribed medications to AD patients are the 
cholinesterase inhibitors such as Donepezil (Fisher, 2008).   
1.3   Glutamate 
 Glutamate is the most abundant excitatory neurotransmitter in the vertebrate 
central nervous system (Meldrum, 2000). Similar to ACh, glutamate must be released 
from synaptic vesicles and the transport of glutamate into vesicles is mediated by 
vesicular glutamate transporter (VGLUT). To date, three different subtypes of VGLUT 
(VGLUT1, 2 and 3) have been identified. VGLUT1 and VGLUT2 are the dominant 
isoforms within central nervous system with high level of expression within hippocampus 
(Balschun et al., 2010). During early postnatal stages, VGLUT2 expression switches to 
VGLUT1 (Myazaki et al., 2003). Several neurological disorders including depression, 
Alzheimer’s disease and Parkinson’s disease have been linked to disruption of VGLUT1 
and VGLUT2 (Moutsimilli et al., 2005; Kashani et al., 2006; Kirvell et al., 2006). 
Tordera et al. (2007) reported that mice with heterozygous knock down of VGLUT1 were 
impaired in long-term memory in the novel object recognition task. In another study, 
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deletion of VGLUT1 resulted in impaired hippocampal LTP in the CA1 region which 
was accompanied by a deficiency in spatial reversal learning (Balschun et al., 2010).  
 Glutamate receptors are divided into ionotropic and metabotropic receptors. 
Metabotropic receptors are indirectly gated G-protein coupled receptors, and ionotropic 
receptors are directly gated ion channels. Ionotropic receptors consist of N-methyl-D-
aspartate (NMDA) and the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
(AMPA) receptor subtypes. NMDA receptors regulate the most common type of LTP in 
the CA1 region and dentate gyrus of the hippocampus (Harris et al., 1984; Malenka and 
Nicoll, 1993). Ca2+ entry through the NMDA receptor is essential for LTP. Downstream 
signaling effects of Ca2+ are believed to be mediated by the α-calcium-calmodulin-
dependent proteinkinase II (CaMKII). While blocking the rise in postsynaptic Ca2+ 
prevents the induction of LTP, increasing the amount of postsynaptic Ca2+ by photolysis 
of caged Ca2+ can mimic LTP (Malenka et al., 1988). Research in behaving rats 
confirmed that hippocampal LTP at different synapses has different sensitivity to NMDA 
receptor antagonists (Leung and Shen, 1999). Non-NMDA dependent types of LTP have 
also been found at the mossy fiber to CA3, and Schaffer collaterals to CA1 (Zalutsky and 
Nicoll, 1990; Hanse and Gustafsson, 1994). This type of LTP may be mediated by 
voltage-gated Ca2+ channels (Johnston et al., 1992).  
1.4   Subcortical inputs to the hippocampus 
Neurons of the hippocampus receive inputs from many parts of the brain extrinsic 
to the hippocampus. Other than the entorhinal cortex, the major subcortical extrinsic 
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inputs to the hippocampus comes from the medial septum (MS) and vertical limb of the 
diagonal band of Broca (DBB).    
1.4.1   Septohippocampal pathway 
Medial septum and diagonal band of Broca (MS-DBB) are parts of the septal 
region that project to the hippocampus by four pathways: the fornix, the supracallosal 
striae, the fimbria, and the amygdalofugal route (Gaykema et al., 1990). Neurons located 
laterally in the medial septum project axons to the medial entorhinal cortex and ventral 
hippocampus (Gaykema et al., 1990). Lateral entorhinal cortex and dorsal hippocampus 
are innervated by neurons located in the medial portion of the MS and also by afferent 
inputs from caudal ventral limb of DBB and medial horizontal limb of DBB (Gaykema et 
al., 1990).  
Immunohistochemical studies revealed three types of neurons projecting from 
MS-DBB to the hippocampus. These neurons were classified as both excitatory and 
inhibitory neurons. Cholinergic and glutamatergic neurons are excitatory while 
GABAergic neurons are inhibitory (Amaral and Kurz 1985; Manns et al., 2003; Sotty et 
al, 2003; Colom et al., 2005; Huh et al. 2010). Furthermore, firing patterns of MS-DBB 
neurons were classified based on characteristics such as the maximum firing frequency, 
duration of the after-hyperpolarizing potential, and the prominence of a 
hyperpolarization-activated current (Griffith et al., 1988; Serafin et al., 1996; Sotty et al., 
2003).  
Cholinergic MS-DBB neurons express choline acetyl transferase (ChAT) and are 
classified as slow-firing cells (Griffith & Matthews, 1986). Cholinergic neurons are 
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mostly located at the caudal and rostral portion of the MS-DBB. Septal cholinergic 
neurons innervate both GABAergic interneurons and the principal cells in the 
hippocampus (Leranth and Frotscher, 1987). On the other hand, septal GABAergic MS-
DBB neurons, which express glutamic acid decarboxylase 67 (GAD67) and parvalbumin 
(Parv), target inhibitory hippocampal interneurons (Freund and Antal, 1988). Two firing 
patterns have been classified for the GABAergic neurons of the MS-DBB: i) fast-firing, 
ii) burst-firing (Morris et al., 1999; Knapp et al., 2000; Sotty et al., 2003). The highest 
density of GABAergic neurons is located on the middle portion of MS-DBB. 
 The third type of the MS-DBB neurons are glutamatergic neurons identified 
using vesicular glutamate transporter 2 (VGLUT2) (Sotty et al., 2003). These neurons 
constitute 4-23% of the projections from MS-DBB to the principal neurons of the CA1, 
CA3, and DG of the hippoampus and are distributed evenly within the MS-DBB (Colom 
et al., 2005, Huh et al., 2010). Glutamatergic neurons of MS-DBB fire in highly 
heterogeneous patterns including: slow-firing, fast-firing, burst-firing and cluster-firing 
which is unique to these neurons (Huh et al., 2010). Fast-firing glutamatergic MS-DBB 
neurons are the most abundant type with greatest concentration near the midline of the 
medial septum similar to the fast-firing GABAergic MS-DBB neurons (Huh et al., 2010). 
In addition to innervating the GABAergic and cholinergic neurons in the MS-DBB, 
septohippocampal glutamatergic neurons also innervate the inhibitory GABAergic 
interneurons and principal neurons in the hippocampus. 
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1.4.2   Brainstem to medial septum 
Reticularis pontis oralis (RPO) and pedunclulopontine tegmental nucleus (PPT) 
are the two structures within the brainstem that provide ascending pathways to the medial 
septum (Macadar et al., 1974; Vertes, 1981; Vertes et al., 1993; Oddie et al., 1994). 
Neurons of the PPT innervate the supramammillary nucleus (SUM) and the septum while 
those ascending from RPO project to the posterior hypothalamic nucleus (PH). A series 
of experiments performed by microinfusion of cholinergic agonist carbachol into the 
PPT, PRO, SUM, and PH followed by recording LFP from the hippocampus revealed 
that majority of the ascending pathways originating from brainstem (PPT and RPO) and 
later from hypothalamic nuclei (SUM and PH) are cholinergic and are excitatory (Oddie 
et al., 1994). Neurons projecting from SUM to MS-DBB form synapses with both 
cholinergic and GABAergic neurons (Borhegyi et al., 1997). Furthermore, SUM also 
projects directly to the hippocampus innervating both principal cells (granule and 
pyramidal cells) and the GABAergic interneurons (Wyss et al., 1979; Haguland et al., 
1984; Vertes, 1992; Nitsch and Leranth, 1996). In addition to the cholinergic projections 
a population of SUM neurons sends glutamatergic afferents to both MS-DBB and 
hippocampus (Kiss et al., 2000). 
1.5   Hippocampal theta rhythm 
The hippocampus produces a sinusoidal-like field potential that occurs at 
frequencies 4–10 Hz known as theta rhythm or rhythmical slow-wave activity (RSA). It 
has been shown that different neurotransmitters regulate the generation of hippocampal 
theta rhythm during different behaviors. Hippocampal theta rhythm is suggested to be 
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involved in attention, learning and memory formation, and the integration of motor 
programming.  
1.5.1   Septal generation of the hippocampal theta rhythm 
 Medial septum and the vertical limb of the diagonal band of Broca (MS-DBB) are 
parts of the septal region that appear to be the most critical system for generating and 
maintaining the hippocampal theta oscillations in vivo. Lesion of the MS-DBB resulted 
in complete loss of the hippocampal theta rhythm in animals (Green and Arduini, 1954). 
Microinfusion of the cholinergic agonist carbachol into the medial septum of both 
anesthetized (Oddie et al., 1994) and freely behaving rats (Lawson and Bland, 1993) 
induced theta activity in the hippocampus. Intraseptal injection of muscimol, a GABA-A 
receptor agonist, abolished the theta rhythm (Oddie et al., 1996). However, intraseptal 
injection of 192 IgG-saporin a selective cholinergic neuron toxin in the septum, only 
decreased power of theta during walking, but failed to decrease the theta peak frequency 
in the behaving rats (Lee et al., 1994). Stimulation of septohippocampal cholinergic 
neurons of mice using optogenetics induced theta oscillations in urethane-anesthetized 
mice but not in walking mice (Vandecasteele et al., 2014). Optogenetic stimulation of 
septal cholinergic neurons significantly suppressed the power of LIA both during 
anesthesia and walking (Vandecasteele et al., 2014). Direct application of atropine to the 
MS eliminated the atropine-sensitive theta rhythm in the hippocampus in the rat under 
urethane anesthesia (Stewart and Fox, 1989). Medial septal injection of NMDA receptor 
antagonist decreased the amplitude of the hippocampal theta rhythm but not the 
frequency (Leung and Shen, 2004). This suppression of amplitude but not frequency was 
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similar to medial septal injection of the GABA-A receptor agonist muscimol (Bland et 
al., 1996). The frequency of theta has been suggested to come from the SUM in the 
hypothalamus (Kirk et al., 1998). 
 A model was proposed by Colom (2006) regarding the role of septohippocampal 
neurons in generation of the hippocampal theta rhythm. Based on this model, septo-
hippocampal glutamatergic neurons get excited upon activation of septal cholinergic 
neurons. Excitation of gluamatergic neurons in conjunction with septal cholinergic cells 
provide the necessary excitatory background to initiate the theta frequency oscillations 
within hippocampus (Colom et al., 2006). At the same time, both septal cholinergic and 
glutamatergic neurons innervate the inhibitory GABAergic interneurons which allow the 
septal network to oscillate at theta frequencies (Colom et al., 2006). Rhythmic firing of 
the septohippocampal GABAergic neurons leads to rhythmic disinhibition of pyramidal 
cells of the hippocampus at the cell body region.  
   Multiple in-vitro studies have suggested that isolated hippocampus may show an 
intrinsic theta oscillation after cholinergic activation (Konopacki et al. 1987). 
Administration of a glutamatergic receptor agonist (S)-3,5-dihyroxyphenylglycine 
(DHPG), to isolated hippocampal slices induced a high frequency (6-10 Hz) theta rhythm 
(Gillies et al., 2002). Intrinsic theta oscillations in single cells are called membrane 
potential oscillations (MPOs). Depolarization of single hippocampal neurons, in the 
absence of synaptic transmission, is sufficient to induce theta-frequency MPOs, 
suggesting that MPOs arise from intrinsic properties of membrane currents (Leung and 
Yim, 1991; Leung, 2012). Theta generation from hippocampus itself was also reported in 
whole hippocampus preparation in vitro (Goutagny et al., 2009). 
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1.5.2   Two types of hippocampal theta rhythm 
 Vanderwolf first discovered a strong correlation between the moment-to-moment 
behavior and hippocampal EEG in behaving rats (Vanderwolf, 1969). Voluntary 
movements such as walking, running, and jumping (also known as Type 1 Behavior) and 
rapid eye movement (REM) sleep are accompanied by generation of high-frequency (6-
10 Hz) and high-amplitude theta oscillations (Vanderwolf, 1969; Vanderwolf, 1975; 
Leung et al., 1982; Oddie and Bland, 1998). Theta rhythm can also be recorded from 
animals under anesthesia during electrical stimulation of the brainstem or in response to 
sensory stimuli (Stumpf, 1965a; Green, 1964; Bland, 1986; Herreras et al., 1988).  
Awake-immobility (also known as Type 2 behavior) with the head held up against 
gravity and eyes open is accompanied by generation of a different theta rhythm 
(Vanderwolf, 1975). Theta oscillations during this type of behavior have a lower 
frequency (4-6 Hz) and are lower amplitude as compared to those recorded during 
voluntary movement (Vanderwolf, 1975; Bland and Oddie, 2001). During more 
autonomic behaviors including licking, chewing, and shivering and also during 
immobility large amplitude irregular activity (LIA) can be recorded in the hippocampus 
(Vanderwolf, 1969; Leung et al., 1982; Bland, 1986). Non-REM sleep and anesthesia are 
associated with slow oscillations (Wolansky et al., 2006).   
 
The theta rhythm during different behaviors shows different pharmacological 
properties, suggesting the participation of different neurotransmitters during different 
behaviors (Vanderwolf, 1988; Dudar et al., 1979; Leung et al., 1982; Sainsbury et al., 
1987; Leung 1998; Tai et al., 2011). Administration of cholinergic antagonists abolishes 
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the theta rhythm during awake-immobility (also known as Type 2 behaviors). Type 2 
behaviors are also referred to as atropine-sensitive (Vanderwolf, 1975; Bland and Oddie, 
2001). Furthermore, injection of cholinesterase inhibitors such as eserine induces 
atropine-sensitive theta (Bland, 1986). In another study by Tai et al. (2011) a continuous 
atropine-sensitive hippocampal theta rhythm was induced by vestibular stimulation 
during rotation when rats were immobile. Injection of atropine abolished this rotation-
induced theta further demonstrates the role of cholinergic neurons in generation of 
hippocampal theta rhythm during Type 2 behaviors (Tai et al., 2011).    
Theta rhythm which occurs along with voluntary movements (also known as Type 
1 behaviors) is atropine-resistant. Injection of cholinergic antagonist drugs such as 
atropine sulphate and scopolamine, even at high doses, fails to abolish the theta rhythm 
during Type 1 behaviors. However, it is known that ACh was released in higher level in 
the hippocampus during Type 1 than Type 2 behaviors (Dudar et al., 1979), and ACh had 
stronger effect on hippocampal electrophysiological responses during walking than 
immobility (Leung, 1998). Other than ACh, several neurotransmitters may participate in 
the generation of atropine-resistant theta. Vanderwolf (1988) inferred that serotonin (5-
HT) mediates the atropine-resistant theta rhythm because the combination of centrally 
acting atropine and 5-HT depletion in the hippocampus abolished the theta rhythm during 
Type 1 behaviors. 5-HT depletion was done by various means, including chemical 
depletion, selective lesion of median raphe neurons, sectioning of presumed 5-HT 
pathway to the hippocampus (Vanderwolf, 1988). Glutamate NMDA receptors in the 
septum and hippocampus may also be part of the atropine-resistant theta (Buzsaki, 2002; 
Leung and Desborough, 1988). NMDA receptor antagonist 2-amino-5-phosphonovaleric 
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acid administered in the medial septum or intracerebroventricularly attenuated the 
atropine-resistant theta in behaving rats (Leung and Desborough, 1988; Leung and Shen, 
2004). Burst firing of the septohippocampal GABAergic neurons driving inhibitory 
hippocampal interneurons (Stewart and Fox, 1990) may be yet another component of the 
atropine-resistant theta rhythm. Septohippocampal GABAergic neurons are suggested to 
be critical for pacing hippocampal theta (Simon et al., 2006; Hangya et al., 2009). 
Creation of these two genetically modified lines of mice was another approach to 
further prove that two types of theta oscillations co-exist. Shin et al. (2005) provided data 
showing that mice lacking phospholipase C (PLC)-ß1 lack one subset of the hippocampal 
theta rhythm. (PLC)-ß1 is one of the four PLC- ß isoenzymes that is highly expressed in 
the hippocampus within the septohippocampal pathway. Furthermore, PLC- ß1 is coupled 
to both muscarinic cholinergic receptors and to group I mGluRs in the hippocampus 
(Bland, 1986; Vertes and Kocsis, 1997; Stewart and Fox, 1990; Chuang et al., 2001). 
PLC-ß1-/- mice lacked the atropine-sensitive subtype of hippocampal theta rhythm 
observed during Type 2 behaviors while the atropine-resistant theta rhythm during Type 
1 behaviors was intact (Shin et al., 2005).  
1.5.3   Functions of the hippocampal theta rhythm  
 Synaptic plasticity within the hippocampus can be induced readily by burst 
stimulation at a theta frequency (Larson et al., 1986). Other studies showed that induction 
of LTP or LTD in the hippocampus depends on the phase of the theta during which 
stimulation was applied. Tetanic burst stimulation delivered on the peak of the theta 
rhythm recorded during Type 1 behavior induced LTP in stratum radiatum of CA1 region 
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of hippocampus; however, stimulation at the trough of the theta induced LTD (Hyman et 
al., 2003). The theta rhythm is believed to be important in spatial memory (Winson, 
1978). After electrolytic lesion of the medial septum, rats were without a theta rhythm, 
and no longer able to perform the spatial tasks (Winson, 1978). 
The hippocampal theta rhythm has a critical role in integration of sensory 
information and the neuronal processing required for the initiation of voluntary 
movements. Vanderwolf (1969) proposed that sensory processing in the hippocampus is 
accompanied by generation of the atropine-sensitive theta. Once a voluntary movement 
initiates, atropine-sensitive theta co-occurs with the atropine-resistant theta (Bland and 
Oddie, 1998). On the other hand, atropine-resistant theta rhythm is an indicator of the 
level of activation of motor systems engaged in voluntary movement (Vanderwolf, 1969). 
During Type 1 behaviors, frequency of the theta rhythm is linearly related to the speed of 
the movement while the amplitude of theta is linearly related with the magnitude of the 
movement (Vanderwolf, 1969). In an experiment performed by Bland et al. (2006), rats 
were trained to jump to the ledge (height adjustable) of a box in order to avoid shock. 
Rats produced atropine-sensitive theta just prior to jump avoidance response. Theta 
frequency increased as the height increased while amplitude of theta decreased (Bland et 
al. 2006).  
1.6   Hippocampal gamma rhythm 
 Another type of oscillations that can be recorded from the hippocampus is the 
relatively high frequency gamma oscillations (30-150 Hz). Hippocampal gamma and 
theta rhythms appear to be independently generated (Leung et al., 1982; Leung 1992). In 
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the absence of theta rhythm, the power and regularity of gamma oscillation decrease and 
a slow irregular pattern of activity appears (Vanderwolf, 1969; Leung et al., 1982). 
Entorhinal cortex and the CA3 region of the hippocampus have been identified as the two 
independent generators of the hippocampal gamma rhythm (Bragin et al., 1995; Csicsvari 
et al., 2003; Colgin et al., 2009).  
Using current source density (CSD) analysis, the largest estimated gamma-
associated excitatory currents were found in the middle third of the dentate gyrus 
molecular layer (Bragin et al., 1995). Medial entorhinal cortex projections terminate in 
this zone of dentate gyrus (Bragin et al., 1995). Furthermore, lesions of the entorhinal 
cortex caused the gamma-associated excitatory currents to attenuate (Bragin et al., 1995). 
The gamma recorded in this region is coherent with excitatory currents recorded from 
stratum lacunosum layer of CA1 region which also receives inputs from entorhinal cortex 
(Charpak et el., 1995). In the study by Csicsvari et al. (2003), when the CA1 region of the 
hippocampus was set as the reference for detecting gamma, excitatory currents emerged 
from CA3. Although two gamma oscillators were reported to be usually independent, 
they can sometimes couple with each other (Colgin et al., 2009). It has been suggested 
that gamma oscillations generated via two different oscillators may produce different 
frequency bandwidths (Colgin et al., 2009). Low and high frequency gamma rhythms are 
correlated with CA3 and entorhinal cortex projections respectively. Low frequency 
gamma (~25-50 Hz) is most abundant during the descending part of the theta rhythm 
while high frequency gamma (~65-150 Hz) is maximal close to a theta rhythm trough 
(Bragin et al., 1995; Csicsvari et al., 2003; Colgin et al., 2009). 
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Many studies have supported the idea that gamma rhythm generation plays a role 
in both encoding and retrieval of memories. When human subjects were asked to 
remember lists of random words, intracranial recordings revealed an increase of gamma 
power during encoding the words that were subsequently recalled (Sederberg et al., 
2007). In another study in behaving rats, it was concluded that high frequency gamma 
oscillations recorded from the CA1 region facilitated memory encoding since direct 
entorhinal cortex projections to CA1 convey information about the animal’s current 
position in environment (Brun et al., 2008; Colgin et al., 2009). On the other hand, the 
amplitude of low frequency gamma oscillations originating from CA3 increased as 
animals learned to accurately perform a task that involved memory retrieval (Tort et al., 
2009). Both memory retrieval and low frequency gamma rhythm are associated with 
increased gamma coherence between CA3 and CA1 while encoding memory and high 
frequency gamma are associated with increased gamma coherence between entorhinal 
cortex and CA1 region of hippocampus (Charpak et el., 1995; Montgomery and Buzsaki, 
2007; Colgin et al. 2009).  
1.7   Mice deficient for the vesicular acetylcholine transporter 
Vesicular acetylcholine transporter (VAChT) is a twelve-transmembrane domain 
protein that stores ACh in synaptic vesicles by means of the electrochemical gradient 
produced by a V-type proton ATPase (Roghani et al., 1994). Proper storage of ACh in the 
synaptic vesicles via VAChT is necessary for efficient release of ACh from nerve 
endings (Parsons, 2000). A reduction of VAChT expression may result in a cholinergic 
deficit because of reduction of release of ACh into the synaptic cleft (Chen et al. 2011).  
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1.7.1   Heterozygous vesicular acetylcholine knock down mice 
Prado et al. (2006) generated a line of genetically modified mice, named VAChT 
KDHET, with selective knock down of VAChT gene. These mice were generated by 
targeting the 5’ untranslated region of the VAChT gene by homologous recombination in 
a mixed 129S6/ SvEvTac (129S6) x C57BL/6J background and were backcrossed to 
C57BL/6/Uni for three generations (Prado et al., 2006). Due to altered expression of 
VAChT mRNA, these mice had 45% less VAChT protein within their central nervous 
system. Despite enhanced intracellular content of ACh (measured by high-performance 
liquid chromatography), release of ACh was reduced to almost 33%. Previous studies 
revealed that both muscarinic and nicotininc receptors played a role in social memory in 
mice (Kampen et al., 2004; Prediger et al, 2006). Consistent with these studies, VAChT 
KDHET mice had a significant deficit in social recognition and were clearly impaired in 
remembering intruder mice when compared to wild-type mice (Prado et al., 2006). 
Similar to certain mouse models of AD (Dewachter et al., 2002) that had object 
recognition alterations, VAChT KDHET mice performed worse in object recognition tests 
as compared to the wild-type mice (Prado et al., 2006). In another experiment by de 
Castro et al. (2009), VAChT KDHET mice were injected with the cholinesterase inhibitor 
galantamine in order to clarify whether decreased VAChT levels affect encoding or 
retrieval of object recognition memory. Results indicated that increase of the cholinergic 
tone facilitated encoding information more effectively (de Castro et al., 2009). 
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1.7.2   Selective basal forebrain VAChT knock out mice 
 Martin-Silva et al. (2011) introduced a novel genetically modified mouse named 
VAChTFloxNeo/FloxNeo (Fig 1B). In order to generate these mice, one LoxP sequence was 
placed 260 bp upstream of the VAChT translational initiation codon. A second LoxP was 
added approximately 1.5kp downstream from the stop codon immediately followed by 
the Neomicin-resistance gene (TK-Neo cassette) which was followed by a third LoxP 
(Martin-Silva et al., 2011; Fig 1B). The embryonic stem cells were injected into 
C57BL/6J blastocytes to achieve the germ line transmission (Martin-Silva et al., 2011). 
Chimeric mice were bred with C57BL/6J mice and heterozygous mice generated (Martin-
Silva et al., 2011). Finally, VAChTFloxNeo/WT mice were intercrossed and homozygous 
VAChTFloxNeo/FloxNeo mice were generated (Martin-Silva et al., 2011; Fig 1B). 
VAChTFloxNeo/FloxNeo had a 75% reduction of VAChT mRNA expression in brain. An 
increase of 1.4 fold in locomotion in open field was found in VAChTFloxNeo/FloxNeo mice as 
compared to wild-type mice (Martin-Silva et al., 2011). The Neo cassette was removed 
from VAChTFloxNeo/FloxNeo mice and VAChTFlox/Flox mice was generated. 
 The Nkx2.1Cre mice were generated in the C57/BL6 strain by pronuclear 
injection of linearized bacterial artificial chromosome (BAC) in which fifteen base pairs 
at the 5ʹ of exon 2 were replaced with Cre-polyA (Xu et al. 2008; Fig 1A). These mice 
were previously used to remove choline acetyltransferase from the forebrain (Patel et al., 
2012). The Nkx2.1Cre mice were crossed with VAChTFlox/Flox mice and VAChTNkx2.1-Cre-
flox/flox
 mice were generated which have a selective knock out of VAChT specific to basal 
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forebrain including the septohippocampal cholinergic neurons (Al-Onaizi et al., under 
review). 
A
B
 
Figure 1 Schematic drawing of generation of Nkx2.1Cre and VAChTFloxNeo/FloxNeo mice. 
A) Fifteen base pairs at the 5’ of exon 2, including the ATG, were replaced with Cre-
polyA (Xu et al., 2008). B) Boxes represent the different exons of ChAT or VAChT. The 
position of the initiation codon (ATG) for VAChT and ChAT and the stop codon (Stop) 
of VAChT are indicated. Potential transcription initiation sites are indicated for VAChT 
(green arrowheads) and ChAT (orange arrowheads). Note that the VAChT gene is within 
the first intron of ChAT (Martin-Silva et al. 2011). 
 
1.8   Rationale and hypothesis 
In rodents, activation of the hippocampus is manifested by increase in theta (4-10 
Hz) and gamma (30-100 Hz) oscillations in the electroencephalogram (EEG). 
Acetylcholine (ACh) has a critical role in cortical activation and modulation of cognitive 
function and synaptic plasticity (Rasmusson, 2000). The hippocampal theta rhythm 
during awake-immobility consists of a cholinergic component (Vanderwolf, 1988; 
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Leung, 1998). Disruption of the central ACh function is an early pathology of 
Alzheimer’s disease (Francis et al., 1999; Coben, 1985). Mice with heterozygous knock 
down of the VAChT gene (VAChT KDHET) showed reduction in release of ACh from 
central cholinergic nerve terminals of ~ 33% (Prado et al., 2006). Mice with forebrain 
knockout of the VAChT gene (Martyn et al., 2012) had negligible ACh release within 
their forebrain. While multiple behavioral deficits were observed in these genetically 
modified mice with reduced levels of VAChT, the electrophysiological substrate for these 
changes has not been studied. Therefore, whether hippocampal activation is affected in 
these two mutant mouse lines is unknown.  
We first aimed to record local field potentials (LFPs) from CA1 region (stratum 
radiatum) of hippocampus of these two genetically modified lines of mice during walking 
and awake-immobility. Their wild-type littermates were used as control. We 
hypothesized that mutant mice will manifest hippocampal theta and gamma rhythms 
different from control mice. Second, we explored the effect of administration of a 
muscarinic cholinergic antagonist drug on hippocampal activation of such genetically 
modified mice during different behaviors. We hypothesized that sensitivity of 
hippocampal activation of both lines of genetically modified mice to the drug will be 
similar to the control mice as their deficiency is in expression of VAChT and not the 
muscarinic receptor. Finally, we investigated the role of glutamatergic neurons in 
generation of theta and gamma rhythms during different behaviors in these genetically 
modified mice by injecting the NMDA receptor antagonist 3-[(R)-2-carboxypiperazin-4-
yl]-prop-2-enyl-1-phosphonic acid (CPP). We hypothesized that administration of CPP 
will cause abnormal hippocampal activation of all mice especially during walking. 
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2 Material and methods 
2.1 Mutant and control mice 
The experiments were performed on two groups of genetically modified. The first 
group of mutant mice, named VAChT KDHET, had a heterozygous knock-down of the 
vesicular acetylcholine transporter (VAChT) in the brain (Prado et al., 2006). VAChT is 
responsible for packaging and release of acetylcholine from synapses. Heterozygous 
mutant VAChT mice (VAChT KDHET) were backcrossed with C57BL/6J animals for 
three generations (Prado et al. 2006). Three of their wild-type littermates were used as 
control mice.  
The second group of mice, named VAChTNkx2.1-Cre-flox/flox(+,+), had VAChT 
deletion restricted to the forebrain, by crossing Nkx2.1-Cre mouse line (C57BL/6J-
Tg(Nkx2-1- cre)2Sand/J), with VAChTflox/flox mice (crossed for 5 generations with 
C57BL/6J) (Al-Onaizi et al., under review). Three of the VAChTNkx2.1-Cre-flox/flox(+,+) mice 
littermates were used as control mice. These control mice had the LoxP however 
expression of VAChT was not affected and they were named VAChTNkx2.1-Cre-flox/flox(-,-). 
Hereafter, control mice including both wild-type and VAChTNkx2.1-Cre-flox/flox(-,-) 
mice will be referred to as WT (Wild-Type) mice, VAChT KDHET will be referred to as 
HET (Heterozygous) mice and VAChTNkx2.1-Cre-flox/flox(+,+) mice will be referred to as KO 
(Knock Out) mice. Mice were housed in groups of 3 to 4 in each cage, with food and 
water available ad libitum. Temperature of the room was maintained at 22°C ± 1 with 
with a 12/12 h light/dark cycle beginning at 7 a.m. All surgical and experimental 
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procedures were approved by the Animal Use Subcommittee of the University of 
Western Ontario Council on Animal Care, in accordance with Canadian Council of 
Animal Care policy. 
2.2 Electrode implantation 
The experiments were conducted on 18 adult male mice 6 HET mice, 6 KO mice, 
and 6 WT mice (3 of which were littermates of HET mice and the other 3 littermates of 
KO mice) weighing 28-54 g. Animals were anesthetized with ketamine (100 mg/kg) and 
xylazine (25 mg/kg) in 0.9% saline (intraperitoneal, i.p.). During the surgery, anesthetic 
condition of the animal was tested every 20 minutes by toe pinching and a supplementary 
dose was injected if needed. The head of the animal was fixed on to a stereotaxic frame 
using blunt ear bars and the skull was adjusted to fit the lambda and bregma in the same 
horizontal plane. Throughout the implantation, body temperature was maintained 
between 35-37°C using a rectal thermometer. The skull was exposed and two small holes 
were drilled bilaterally over the hippocampal CA1 region (AP -2.3 mm, L ± 1.6 mm) 
based on the coordinates of the mouse brain atlas (Franklin and Paxinos 1998). An 
electrode comprised of a 125-µm Teflon-insulated stainless steel wire recording from one 
cut end, and soldered to a female miniature connector at the other end. Two electrodes 
were bundled together for placement in the CA1 region of the hippocampus with the deep 
electrode targeting the stratum radiatum and the shallow one targeting the alveus. A small 
hole was drilled over the left cerebellum and another one drilled over the right frontal 
cortex. A jeweller’s screw was placed over each of these holes and served as a recording 
ground. Next, a thin layer of cyanoacrylate (Krazy Glue) was applied over the skull. 
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Finally, electrodes and screws were fixed using dental cement. In order to avoid loss of 
the head cap, mice were housed individually in a large cage (25cm x 40cm x 15cm) after 
the implantation. 
2.3 Recording and analysis 
The mice were allowed 4-6 days to recover from surgery. Later, a cable was 
connected to the electrodes via the female miniature connector pins on the head cap. A 
mouse was placed in a cubic plastic cage (30 cm x 30 cm x 30 cm) and allowed to 
habituate for 10 minutes to the recording environment. Hippocampal LFP was recorded 
from the freely behaving mouse during periods of awake-immobility and walking. The 
behavior of the mouse was visually monitored and annotated during the recording of 
LFP. A mouse was considered to be awake-immobile when it was motionless in an alert 
state with its head held up against gravity and eyes open. Ear flicks, eye blinks and 
movement of nostril during immobility were also included as part of the awake-
immobility behavior. Besides the regular walking, other behaviors including running, 
rearing, turning, digging and postural movements were also considered as walking 
behavior. Hippocampal LFP was recorded for 30-45 minutes (each record was 60 
seconds long) from the mouse as a baseline condition. Then, 5 mg/kg i.p. scopolamine 
hydrochloride (muscarinic cholinergic antagonist) was injected (i.p.), and LFP recordings 
stated 10 minutes after injection for another 30-45 minutes. A week after the first 
recording, mice were experimented again under the same procedure however during the 
second recording instead of scopolamine a 10 mg/kg i.p. dose of NMDA receptor 
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antagonist CPP (3-[(R)-2-carboxypiperazin-4-yl]-prop-2-enyl-1-phosphonic acid) was 
injected.  
The power spectrum was constructed from averaging at least 15 segments LFP of 
each behavior (awake-immobility or walking), either for baseline or after injection of a 
drug. Segments of the LFP recordings were selected manually in order to eliminate any 
artifacts. Each segment was 1024 points or 5.12 s with 200 Hz sampling (Leung et al., 
1982). Six average power spectra were plotted for each mouse, for the following 
condition: i) awake-immobility, ii) scopolamine awake-immobility, iii) CPP awake-
immobility, iv) baseline walking, v) scopolamine walking and vi) CPP walking. Each 
spectrum had a frequency resolution of 0.19 Hz (1/5.12 s), and elliptical smoothing over 
5 bins made statistically independent values were separated by 5 bins, or 0.95 Hz, but 
with more than 150 degrees of freedom. Power spectra were plotted in arbitrary 
logarithmic units, with the calibration of 5.43 log units = 1 mV peak-to-peak amplitude 
of a sine wave. An increase of 1 logarithmic power unit signified a 10-fold increase in the 
squared amplitude of the LFP at a specific frequency.  
2.4   Histology 
At the end of experiments, mice were deeply anesthetized with 30% urethane and 
perfused through the heart with 100 ml of cold saline followed by 100 ml of cold 4% 
formaldehyde. The brain was extracted from the cranium and placed in 4% formaldehyde 
solution until ready for sectioning. Coronal brain sections of 40 µm thick were cut using 
a freezing microtome and mounted on slides and stained with thionin. Electrode 
 placements were verified
were taken from brain sections using a digital camera. 
 
  
Figure 2 Top: Hippocampal CA1 region (AP 
coordinates of the mouse 
sections (left and right side) 
verified by magnification of
 
 by 100X magnification of the slides using a microscope
 
-2.3 mm, L ± 1.6 mm) based on the 
brain atlas (Franklin and Paxinos 1998) Bottom: 
stained with thionin. Electrode placements (red arrows) 
 the slides using a microscope. 
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2.5   Statistical analysis 
Four measures were obtained from each power spectrum derived from a single 
mouse: i) theta peak frequency (3-10 Hz), ii) theta peak rise (logarithmic units), iii) 
average logarithmic power of low gamma frequency (30-58 Hz) and iv) average 
logarithmic power of the high gamma frequency (62-100 Hz). The theta peak rise is the 
difference between the power (in logarithmic units) at the theta peak (maximum) and the 
power of the valley (minimum) immediately before the theta peak. Theta peak rise gives 
an indication of the power of the rhythmic oscillations at the theta frequency. All data 
were expressed as mean ± standard error of the mean (SEM) when applicable. All 
statistics were performed using the GraphPad Prism 5.0 software. Each of the 4 variables 
introduced above was subjected to several two-way Analysis of Variance (ANOVA) or 
paired t-tests. The groups of mice (WT, HET and KO) was set as a between factor and 
behavior (walking/awake-immobility) was set as a within factor. In some of the two-way 
ANOVAs performed, effect of the drug (scopolamine hydrochloride/CPP) on any of the 
above variables was set as the within factor rather than the behavior. Statistical 
significance was set at P < 0.05. 
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3 Results 
3.1 Baseline LFP recording during awake-immobility and 
walking 
Local field potentials (LFPs) were recorded from CA1 region of hippocampus of 
18 adult male mice (6 Wild-Type mice (WT), 6 VAChT KDHET mice (HET), and 6 
VAChTNkx2.1-Cre-flox/flox mice (KO)). Mice were placed in a cubic cage (30 cm x 30 cm x 
30 cm) and allowed ten minutes to habituate. LFPs were recorded for 30-45 minutes 
while mice were freely behaving. Three of the control mice were wild-type littermates of 
the HET mice and the other three were VAChTNkx2.1-Cre-flox/flox(-,-) mice. No significant 
difference was seen in case of any of the experimental results (theta peak frequency and 
power, low- and high-frequency gamma power, and response to drugs) between these two 
control groups (paired t-tests and 2-way ANOVAs, n = 3, P > 0.05) thus we considered 
them all as WT mice. 
During awake-immobility, the frequency of theta rhythm was stable at ~ 5 Hz as 
indicated by time-frequency spectrogram (Fig. 3B) and the LFPs (Fig. 3C). During 
awake-immobility, the average theta rhythm peak frequency recorded from 6 WT mice 
was 4.47 ± 0.21 Hz (Fig. 6-7), with a rise of theta peak of 0.53 ± 0.03 log unit (Fig. 6-7). 
Theta peak frequency increased to about 8 Hz during walking, as shown by the LFPs and 
spectrogram of a representative mouse (Fig. 3B, C). As a group, theta frequency in WT 
mice was higher during walking as compared to awake-immobility (7.77 ± 0.15 Hz, n = 
6, paired t-test, P < 0.001; Fig. 7). WT mice manifested significantly higher theta power  
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Figure 3 Hippocampal activation of a representative wild-type (WT) mouse. A) 
Representative LFP traces recorded from CA1 stratum radiatum of a WT mouse during 
awake-immobility (top) and walking (bottom). B) Time-frequency spectrogram indicates 
relatively stable theta frequency during 60 sec of recording (horizontal axis); the vertical 
axis represents frequency from 0 to 100 Hz, with color (red: strong, blue: weak) intensity 
calibration in power (dB). 20 dB is equal to 1 log power unit. C) Power spectra of 
hippocampal LFPs during awake-immobility (blue trace) and walking (red trace). Theta 
rhythm during awake-immobility was lower in frequency and amplitude as compared to 
the same measure recorded during walking. Gamma power at 50-100 Hz was higher 
during walking than awake-immobility. 
31 
 
during walking as compared to awake-immobility (0.86 ± 0.07 log units, n = 6, paired t- 
test, P < 0.001; Fig. 7). Low-frequency (30-58 Hz) gamma power did not change 
significantly with behavior (awake-immobility: 2.40 ± 0.09 log units, walking: 2.55 ± 
0.09 log units, n = 6), as confirmed by paired t-test P > 0.05; Fig. 7). However, high-
frequency (62-100 Hz) gamma power was significantly larger during walking as 
compared to awake-immobility (awake-immobility: 1.85 ± 0.09 log units, walking: 2.12 
± 0.12 log units, n = 6), as shown by paired t-test P < 0.001; Fig. 7). 
Theta peak frequency of HET mice during awake-immobility and walking was 
4.92 ± 0.03 Hz and 8.34 ± 0.15 Hz, respectively (n = 6; Fig. 6-7). HET mice showed a 
significantly higher theta power during walking (0.89 ± 0.04 log units) as compared to 
awake-immobility (0.40 ± 0.02 log units, n = 6, paired t-test, P < 0.0001; Fig. 6). Both 
low- and high- frequency gamma power were significantly stronger during walking as 
compared to awake-immobility (n = 6, paired t-test, P < 0.01; Fig. 6). The average 
logarithmic power of low-frequency gamma oscillations of 6 HET mice was 2.60 ± 0.15 
log units during awake-immobility and 2.79 ± 0.08 log units during walking (Fig. 6).  
Higher theta frequencies were found in HET mice as compared to WT mice at a 
fixed behavior (Fig. 7); the difference was statistically significant during walking (2-way 
ANOVA group effect, F
 (1, 10) = 12.87, P < 0.05) but not during awake-immobility. 
During awake-immobility, the theta power in HET mice was lower than that in WT mice 
(2-way ANOVA group effect F
 (1, 10) = 60.29, P < 0.05; Fig. 7). Results of a 2-way 
ANOVA (group x behavior) revealed that between WT and HET mice, there was no 
significant difference in the power of low-frequency gamma rhythm during either of the 
behaviors (F
 (1, 10) = 0.07, P = 0.80; Fig. 7). Similar results were obtained for high  
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Figure 4 Hippocamapal activation of a representative VAChT KDHET mouse. A) LFP 
traces recorded from the CA1 region of the hippocampus of a HET mouse during awake-
immobility (top) and walking (bottom). B) Time-frequency spectrogram indicates stable 
theta frequency during 60 sec of recording, and the higher gamma power during walking 
than immobility. C) Power spectra during awake-immobility (blue trace) and walking 
(red trace). Theta rhythm during awake-immobility was lower in frequency and 
amplitude as compared to the same measure recorded during walking. Power of gamma is 
significantly higher during walking. 
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frequency gamma oscillations (2-way ANOVA group effect, F
 (1, 10) = 0.01, P = 0.91; Fig. 
7).    
Walking in KO mice was accompanied by significantly higher theta power (0.93 
± 0.03 log unit) and higher peak frequency theta rhythm (7.83 ± 0.20 Hz, n = 6, paired t-
test, P < 0.001; Fig. 6) as compared to the same measure during awake-immobility (3.81 
± 0.19 Hz, 0.09 ± 0.02 log unit). Power of the low-frequency gamma in KO mice 
increased significantly during walking (2.86 ± 0.12 log units) as compared to awake-
immobility (2.55 ± 0.13 log units, n = 6, paired t-test, P < 0.001; Fig. 6). Similar results 
were observed for high-frequency gamma power (awake-immobility: 1.76 ± 0.11 log 
units, walking: 2.07 ± 0.11 log unit, n = 6, paired t-test, P < 0.05; Fig. 6).  
Compared with WT mice, KO mice manifested a significantly lower theta peak 
frequency during awake-immobility (2-way ANOVA group factor, F
 (1, 10) = 4.65, P < 
0.05; Fig. 7). Furthermore, awake-immobility theta showed significantly lower power in 
KO mice than in WT mice (2-way ANOVA group factor, F
 (1, 10) = 55.82, P < 0.001; Fig. 
7). No significant difference in theta peak frequency was observed between WT (7.77 ± 
0.15 Hz) and KO mice (7.83 ± 0.20 Hz) during walking (2-way ANOVA group factor, F
 
(1, 10) =0.05, P = 0.83; Fig. 7). Also, there was no significant difference in the walking 
theta power between WT (0.86 ± 0.07 log unit) and KO mice (0.93 ± 0.03 log unit) (2-
way ANOVA group factor, F
 (1, 10) = 0.06, P = 0.82; Fig. 7).  
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Figure 5 Hippocamapl activation of a representative VAChTNkx2.1-Cre-flox/flox mouse. A) 
LFP traces recorded from the CA1 region of the hippocampus of a HET mouse during 
awake-immobility (top) and walking (bottom). B) Time-frequency spectrogram indicates 
stable theta frequency during 60 sec of recording, and the higher gamma power during 
walking than immobility C) Power spectra during awake-immobility (blue trace) and 
walking (red trace). Theta rhythm during awake-immobility was lower in frequency and 
amplitude as compared to the same measure recorded during walking. Power of gamma is 
significantly higher during walking. 
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Figure 6 Effects of behavior on hippocampal activation of WT (n = 6), HET (n = 6), and 
KO (n = 6) mice. Values are expressed as mean ± SEM. * P<0.05, *** P<0.001: 
difference between awake-immobility and walking using repeated measures two-way 
ANOVA followed by Bonferroni test. In each group of mice, theta was higher in power 
and peak frequency, and high-frequency gamma was higher during walking as compared 
to the same measure during awake-immobility. In HET and KO mice, but not in WT 
mice, low-frequency gamma was higher during walking than immobility. 
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Figure 7 Comparison of hippocampal activation of WT (n = 6), HET (n = 6), and KO (n 
= 6) mice. Values are expressed as mean ± SEM. * P<0.05, *** P<0.001: difference 
between groups using repeated measures two-way ANOVA followed by Bonferroni test. 
Awake-immobility: Theta peak frequency is significantly higher in WT mice as compared 
to KO mice. Theta power decreases in the order of WT, HET and KO mice. No 
significant group differences were observed for the power of low- or high-frequency 
gamma rhythm. Walking: HET mice manifested significantly higher theta peak frequency 
as compared to WT mice. Theta power did not differ significantly amongst the groups. 
Low-frequency gamma power of KO mice during walking was significantly stronger than 
WT mice.  
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3.2   Injection of scopolamine hydrochloride 
In order to evaluate the response of mutant mice to a cholinergic antagonist drug, 
mice from all groups were injected with the muscarinic cholinergic antagonist 
scopolamine hydrochloride (5 mg/kg i.p.). Ten minutes post injection, LFPs were 
recorded for another 30 to 45 minutes. Results obtained from both mutant groups were 
compared with the WT mice. 
3.2.1   Wild-type mice 
Scopolamine hydrochloride abolished the awake-immobility hippocampal theta 
rhythm in WT mice (Fig. 8, 14). By contrast, during walking, scopolamine injection 
resulted in a non-significant decrease of theta rhythm peak frequency (7.64 ± 0.32 Hz; n 
= 6; P = 0.72; paired t-test; Fig 9, 15). However, power of theta was suppressed 
significantly after injection of scopolamine (0.44 ± 0.04 log units; n = 6, P < 0.001; 
paired t-test; Fig. 9, 15). A two-factor ANOVA (behavior x drug) followed by Bonferroni 
test was performed to analyze the effects of scopolamine injection on hippocampal 
gamma oscillations. No significant change was observed in power of low frequency 
gamma after administration of scopolamine during both behaviors (n = 6, F
 (1, 10) = 1.77, 
P = 0.21; Fig. 8-9, 14-15). Average logarithmic power of low gamma during awake-
immobility and walking were 2.41 ± 0.11 and 2.62 ± 0.24 log units respectively (Fig. 14, 
15). High frequency gamma power (awake-immobility: 1.87 ± 0. 14 log units, walking: 
2.03 ± 0.16 log units) also did not change significantly after injection of scopolamine (2-
way ANOVA, n = 6, F
 (1, 10) = 0.06, P = 0.81; Fig 8-9, 14-15). 
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Figure 8 Effects of administration of scopolamine on hippocampal activation of a 
representative wild-type mouse during awake-immobility. A) LFP traces (6 seconds) 
before and after scopolamine injection. B) Time-frequency spectrogram and C) Power 
spectra before (red trace) and after administration of scopolamine (blue trace). 
Scopolamine injection abolished the theta peak during awake-immobility, but did not 
change significantly the low- and high-frequency gamma power. 
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Figure 9 Effects of administration of scopolamine on hippocampal activation of a 
representative wild-type mouse during walking. A) LFP traces (6 seconds) before and 
after scopolamine injection. B) Time-frequency spectrogram and C) Power spectra 
representation of hippocampal activation of a WT mouse before and after administration 
of scopolamine. Blue line corresponds to baseline while red line represents post 
scopolamine. Theta power was decreased significantly after scopolamine injection, but its 
peak frequency remained quite intact. Scopolamine injection did not significantly change 
the power of either low or high frequency gamma. 
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3.2.2   VAChT KDHET mice 
Theta rhythm in HET mice was less sensitive to scopolamine as compared to theta 
in WT mice. Scopolamine injection failed to abolish the awake-immobility theta rhythm 
in HET mice; however, both peak frequency and power of theta were significantly 
attenuated (Fig. 10). The lack of scopolamine sensitivity of awake-immobile theta rhythm 
in the hippocampus of HET mice was different from WT mice (3.2.1). Theta peak 
frequency was reduced from 4.92 ± 0.03 Hz to 3.49 ± 0.21 Hz (n = 6, P < 0.01; Fig. 14). 
Scopolamine suppressed the power of theta rhythm during both immobility and walking 
(awake-immobility: before scopolamine: 0.40 ± 0.02 log units, after scopolamine 0.17 ± 
log units, n = 6, P < 0.001; walking: 0.37 ± 0.02 log units while baseline power was 0.89 
± 0.04 log units, n = 6, P < 0.0001; Fig 14-15). Similar to WT mice, the walking theta 
peak frequency was not changed significantly by scopolamine (7.96 ± 0.32 Hz, report 
baseline again n = 6, P = 0.32; Fig. 15). As observed for the WT mice, injection of 
scopolamine to HET mice also did not alter the power of low frequency gamma during 
awake-immobility or walking (2-way repeated measures ANOVA, n = 6 mice, F
 (1, 10) = 
1.33, P = 0.28; Fig. 10-11, 14-15). High frequency gamma power also did not change 
significantly after scopolamine during awake-immobility (1.73 ± 0.12 log units) or during 
walking (1.94 ± 0.12 log units; 2-way ANOVA, n = 6, 2-way repeated measures ANOVA 
F (1, 10) = 0.05, P = 0.82; Fig. 10-11, 14-15). 
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Figure 10 Effects of administration of scopolamine on hippocampal activation of a 
representative VAChT KDHET mouse during awake-immobility. A) LFP traces (6 
seconds) before and after scopolamine injection. B) Time-frequency spectrogram and C) 
Power spectra before (red trace) and after administration of scopolamine (blue trace). 
Scopolamine injection shifted the theta peak to a lower frequency and reduced its power. 
Scopolamine did not change significantly the low- and high-frequency gamma power. 
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Figure 11 Effects of administration of scopolamine on hippocampal activation of a 
representative VAChT KDHET mouse during walking. A) LFP traces (6 seconds) before 
and after scopolamine injection. B) Time-frequency spectrogram and C) Power spectra 
representation of hippocampal activation of a HET mouse before and after administration 
of scopolamine. Blue line corresponds to baseline while red line represents post 
scopolamine. Although power of theta rhythm was significantly suppressed after 
scopolamine injection, its peak frequency remained quite intact. Scopolamine injection 
did not significantly change the power of either low- or high-frequency gamma. 
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3.2.3   VAChTNkx2.1-Cre-flox/flox mice   
Sensitivity of hippocampal LFPs to scopolamine was similar in KO and WT mice. 
Theta generated during awake-immobility was abolished by scopolamine injection (Fig. 
12). Walking-induced theta peak did not change significantly after administration of 
scopolamine (7.79 ± 0.21 Hz, n = 6, P = 0.71, paired t-test; Fig. 13, 15). Unlike in WT 
and HET mice, power of walking-induced theta was not suppressed significantly post 
scopolamine injection (0.83 ± 0.08, n = 6, P = 0.21, paired t-test; Fig. 13, 15). 
Scopolamine also failed to alter the power of low-frequency gamma generated during 
awake-immobility (2.64 ± 0.13 log units; Fig. 14). A similar result was observed for the 
walking-induced low-frequency gamma (2.93 ± 0.15 log units, n = 6, F
 (1, 10) = 0.19, P = 
0.67; Fig. 15). High-frequency gamma during awake-immobility showed a non-
significant increase of power after scopolamine (1.87 ± 0.12 log units, n = 6; Fig. 12, 14). 
Scopolamine injection did not change the power of walking-induced high frequency 
gamma (2.16 ± 0.13 log units, n = 6, F
 (1, 10) = 0.36, P = 0.56; Fig. 13, 15). 
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Figure 12 Effects of administration of scopolamine on hippocampal activation of a 
representative VAChTNkx2.1-Cre-flox/flox mouse during awake-immobility. A) LFP traces (6 
seconds) before and after scopolamine injection. B) Time-frequency spectrogram and C) 
Power spectra before (red trace) and after administration of scopolamine (blue trace). 
Scopolamine injection abolished the theta peak during awake-immobility, but did not 
change significantly the low- and high-frequency gamma power. 
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Figure 13 Effects of administration of scopolamine on hippocampal activation of a 
representative VAChTNkx2.1-Cre-flox/flox mouse during walking. A) LFP traces (6 seconds) 
before and after scopolamine injection. B) Time-frequency spectrogram and C) Power 
spectra representation of hippocampal activation of a KO mouse before and after 
administration of scopolamine. Blue line corresponds to baseline while red line represents 
post scopolamine. Injection of scopolamine failed to alter any of the four variables 
significantly. 
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Figure 14 Effect of scopolamine on hippocampal activation of WT (n = 6), HET (n = 6), 
and KO (n = 6) mice during awake-immobility. Values are expressed as mean ± SEM. * 
P<0.05, *** P<0.001: difference between no drug and scopolamine using repeated 
measures two-way ANOVA followed by Bonferroni test. Scopolamine abolished theta 
peak frequency and power in WT and KO mice, and attenuated theta frequency and 
powerin HET mice. No significant change was noticed in power of gamma in any mouse 
groups after scopolamine. 
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Figure 15 Effect of scopolamine on hippocampal activation of WT (n = 6), HET (n = 6), 
and KO (n = 6) mice during walking. Values are expressed as mean ± SEM. *** 
P<0.001: difference between no drug and scopolamine using repeated measures two-way 
ANOVA followed by Bonferroni test. Theta peak frequency did not change significantly. 
Theta power attenuated in WT and HET mice but not in KO mice. Scopolamine failed to 
alter the power of gamma oscillations in all three groups during walking.  
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3.3   CPP injection 
To investigate the source of compensation which might have happened in HET 
mice, the NMDA receptor antagonist 3-[(R)-2-carboxypiperazin-4-yl]-prop-2-enyl-1-
phosphonic acid (CPP) was injected (10 mg/kg i.p.) to mice from all groups. The LFPs 
were recorded from mice 30 minutes post injection.  
3.3.1   Wild-type mice 
CPP injection did not alter the awake-immobile theta peak frequency significantly 
(3.98 ± 0.21 Hz, n = 6, P = 0.13); however, walking-induced theta peak frequency was 
suppressed significantly (7.01 ± 0.30 Hz, n = 6, P < 0.05) as compared to baseline (7.83 ± 
0.20 Hz). Power of theta was significantly suppressed during awake-immobility and 
walking after injection of CPP (awake-immobility: 0.38 ± 0.04 log units, n = 6, P < 0.05; 
walking: 0.24 ± 0.03 log units, n = 6, P < 0.001). No significant change was observed 
post CPP injection in the power of low frequency gamma oscillations during either of the 
behaviors (awake-immobility: 2.40 ± 0.1 log units; walking: 2.55 ± 0.09; 2-way 
ANOVA, n = 6, F
 (1, 10) = 0.15, P = 0.70; Fig. 16-17, 22-23). There was a non-significant 
increase in power of high frequency gamma during awake-immobility (1.86 ± 0.09 log 
units; Figure 16, 22). Power of high frequency gamma after CPP injection during walking 
was 2.09 ± 0.16 log units, which did not differ from baseline significantly (2-way 
ANOVA, n = 6, F
 (1, 10) = 0.05, P = 0.84; Fig. 17, 23). 
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Figure 16 CPP injection and hippocampal activation in a Wild-Type mouse during 
awake-immobility. A) LFP traces (6 seconds) before and after CPP injection. B) Time-
frequency spectrogram and C) Power spectra representation of hippocampal activation of 
a WT mouse before and after administration of CPP. Blue line corresponds to baseline 
while red line represents post CPP. Power of theta rhythm but not theta peak frequency 
was suppressed significantly by CPP. CPP injection did not significantly change the 
power of either low- or high-frequency gamma. 
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Figure 17 CPP injection and hippocampal activation in a Wild-Type mouse during 
walking. A) LFP traces (6 seconds) before and after CPP injection. B) Time-frequency 
spectrogram and C) Power spectra representation of hippocampal activation of a WT 
mouse before and after administration of CPP. Blue line corresponds to baseline while 
red line represents post CPP. CPP suppressed both power and peak frequency of theta 
rhythm significantly, but it did not significantly change the power of either low- or high-
frequency gamma. 
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3.3.2   VAChT KDHET mice 
Administration of CPP abolished the awake-immobility theta rhythm. A theta 
peak, as indicated by rise of the theta peak, was not detected in any of the six HET mice 
during awake-immobility (Fig. 18). CPP shifted the walking-induced theta rhythm peak 
to a significantly lower frequency (7.59 ± 0.28 Hz; n = 6, P < 0.05, paired t-test; Fig. 19, 
22). Furthermore, power of theta recorded during walking was significantly attenuated 
(3.53 ± 0.02 log units; n = 6, P < 0.0001, paired t-test; Fig. 19, 23). Similar to WT mice, 
low-frequency gamma power in HET mice did not change significantly post CPP (awake-
immobility: 2.60 ± 0.15 log units; walking: 2.79 ± 0.08 log units; 2-way ANOVA, n = 6, 
F
 (1, 10) = 0.40, P = 0.54; Fig. 18-19, 22-23). When compared to baseline recording, power 
of high frequency gamma was not altered significantly post CPP injection (awake-
immobility: 1.96 ± 0.15 log units; walking: 2.11 ± 0.14 log units; 2-way repeated 
measures ANOVA, n = 6, F
 (1, 10) = 0.61, P = 0.45; Fig. 18-19, 22-23). 
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Figure 18 CPP injection and hippocampal activation in a VAChT KDHET mouse during 
awake-immobility. A) LFP traces (6 seconds) before and after CPP injection. B) Time-
frequency spectrogram and C) Power spectra before (blue trace) and after administration 
of CPP (red trace). CPP injection abolished the theta peak during awake-immobility, but 
did not change significantly the low- and high-frequency gamma power.   
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Figure 19 CPP injection and hippocampal activation in a VAChT KDHET mouse during 
walking. A) LFP traces (6 seconds) before and after CPP injection. B) Time-frequency 
spectrogram and C) Power spectra before (blue trace) and after administration of CPP 
(red trace). CPP injection significantly attenuated the power of theta. Theta peak shifted 
to a lower frequency. CPP failed to change the low- and high-frequency gamma power. 
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3.3   VAChTNkx2.1-Cre-flox/flox mice 
CPP injection did not change the peak frequency of awake-immobility theta in the 
KO (VAChTNkx2.1-Cre-flox/flox) mice (4.04 ± 0.19 Hz, n = 6, P = 0.43), but it significantly 
reduced the walking theta frequency (6.91 ± 0.12 Hz, n = 6, P < 0.01). In contrast to WT 
mice, CPP failed to alter the theta power during awake-immobility (0.069 ± 0.02 log 
units, n = 6, P = 0.35). However, theta power during walking (0.29 ± 0.03 log units) was 
suppressed significantly (n = 6, P < 0.0001). Average logarithmic power of low-
frequency gamma rhythm was 2.55 ± 0.12 log units during awake-immobility and 2.86 ± 
0.12 log units while walking (Fig. 22-23). Similar to WT mice, power of both low- and 
high-frequency gamma did not change significantly during awake-immobility or walking 
in response to CPP injection. 
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Figure 20 CPP injection and hippocampal activation in a VAChTNkx2.1-Cre-flox/flox mouse 
during awake-immobility. A) LFP traces (6 seconds) before and after CPP injection. B) 
Time-frequency spectrogram and C) Power spectra representation of hippocampal 
activation of a KO mouse before and after administration of CPP. Blue line corresponds 
to baseline while red line represents post CPP. Injection of CPP failed to alter any of the 
four variables significantly. 
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Figure 21 CPP injection and hippocampal activation in a VAChTNkx2.1-Cre-flox/flox mouse 
during walking. A) LFP traces (6 seconds) before and after CPP injection. B) Time-
frequency spectrogram and C) Power spectra before (blue trace) and after administration 
of CPP (red trace). CPP injection significantly attenuated the power of theta. Theta peak 
shifted to a lower frequency. CPP significantly suppressed the power of low-frequency 
gamma power but not high-frequency gamma power. 
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Figure 22 Effect of CPP on hippocampal activation of WT (n = 6), HET (n = 6), and KO 
(n = 6) mice during awake-immobility. Values are expressed as mean ± SEM. * P<0.05, 
*** P<0.001. Repeated measures two-way ANOVA (behavior x drug) followed by 
Bonferroni test was used. WT Mice: Theta power attenuated while its peak frequency did 
not change significantly. CPP injection failed to alter the power of gamma oscillations. 
HET Mice: Immobile theta peak was not observed, thus zero theta power, and the power 
of low- and high-frequency gamma was not significantly changed after CPP. KO Mice: 
None of the four variables changed significantly after injection of CPP. 
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Figure 23 Effect of CPP on hippocampal activation of WT (n = 6), HET (n = 6), and KO 
(n = 6) mice during walking. Values are expressed as mean ± SEM. * P<0.05, ** P<0.01, 
*** P<0.001. Repeated measures two-way ANOVA (behavior x drug) followed by 
Bonferroni test was used. In all three groups of mice, theta power was strongly attenuated 
after injection of CPP. Theta peak also shifted to a significantly lower frequency in all 
groups. Although CPP suppresses the low-frequency gamma power in KO mice, no 
significant reduction was noticed in WT and HET mice. Power of high-frequency gamma 
did not vary significantly in any of the three groups after administration of CPP.   
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4   Discussion 
4.1   Hippocampal activation during awake-immobility  
My results indicate that two types of theta rhythm are generated within the 
hippocampus based on the behavior. This is consistent with previous findings 
(Vanderwolf, 1969; Vanderwolf, 1975; Leung et al., 1982; Oddie and Bland, 1998; Bland 
and Oddie, 2001). Theta rhythm generated during awake-immobility in all groups of mice 
had significantly lower peak frequency and power as compared with the walking induced 
theta. No significant difference was found in the power of either low- or high-frequency 
gamma activity between groups during awake-immobility. 
Vanderwolf (1988) suggested that different neurotransmitters regulate generation 
of each type of theta rhythm. Multiple studies using cholinergic agonist and antagonist 
drugs showed that acetylcholine (ACh) is the neurotransmitter responsible for generation 
of hippocampal theta rhythm during awake-immobility (Sainsbury et al., 1987; 
Vanderwolf, 1988; Leung 1998; Tai et al., 2011). I found that the power of theta during 
awake-immobility decreased in the order of Wild-Type, VAChT KDHET and 
VAChTNkx2.1-Cre-flox/flox, which is the order of expected availability of synaptically released 
acetylcholine in the septohippocampal system This further suggests that cholinergic 
functionality is necessary for generation of awake-immobility theta.  
The awake-immobility theta is also referred to as atropine-sensitive. Injection of 
scopolamine in all three groups of mice was accompanied by a short period (~5 minutes) 
of hyperactivity followed by a longer period (~20 minutes) of immobility. My data 
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showed that administration of scopolamine abolished the theta generated during awake-
immobility in Wild-Type and VAChTNkx2.1-Cre-flox/flox mice. Atropine-sensitive theta has 
been suggested to indicate sensory processing in the hippocampus (Vanderwolf, 1988). 
Based on this model the atropine-sensitive theta provides sensory information required 
for the initiation of voluntary movement or signal the intensity of an upcoming 
movement. This is consistent with the sensorimotor integration model proposed by Bland 
and Oddie (2001). 
Despite the fact that VAChT was deleted from basal forebrain of the 
VAChTNkx2.1-Cre-flox/flox mice (Al-Onaizi, under review), a low power theta was still 
present during awake-immobility. Two reasons could account for this result. First, some 
ACh is still being released in the septo-hippocampal pathway in these forebrain-VAChT 
knockout mice, despite near zero VAChT levels assessed by protein and mRNA (Al-
Onaizi, under review). Next, cholinergic neurons projecting from pedunculopontine 
tegmental nucleus (PPT) to the medial septum (MS) play a role in generation of atropine-
sensitive theta. Direct application of atropine to the MS eliminated the atropine-sensitive 
theta rhythm in the hippocampus in the rat under urethane anesthesia (Stewart and Fox, 
1989), which may block muscarinic cholinergic synapses on GABAergic 
septohippocampal neurons (Alreja et al., 2000; Wu et al., 2000). Stimulation of PPT or 
infusion of cholinergic agonists into the PPT has been shown to induce hippocampal 
theta (Vertes, 1982; Vertes et al., 1993). 
 Another interesting result was the failure of scopolamine injection in totally 
abolishing the atropine-sensitive theta in VAChT KDHET mice. Administration of 
scopolamine suppressed the theta power significantly and shifted the peak to a lower 
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frequency but failed to abolish it. This suggests that a compensatory mechanism might 
have developed in these mice. Based on the model proposed by Colom (2006), 
septohippocampal cholinergic neurons, in addition to septohippocampal glutamaterigc 
neurons, help to increase the level of excitation within the medial septum to a threshold 
necessary for oscillation in theta frequency. It is possible that the septohippocampal 
glutamatergic neurons release more glutamate in order to compensate for the cholinergic 
deficiency.  
 In another study by Allen et al., (2006), cholinergic basal forebrain neurons (in 
vitro) were shown to be capable of releasing glutamate as a co-transmitter. Co-release of 
glutamate was subjected to the negative-feedback inhibition regulated by the M2 subtype 
muscarinic cholinergic receptors located presynatically. Prado et al., 2006 reported that 
release of ACh was reduced to ~33% in VAChT KDHET mice. In VAChT KDHET mice, 
decreased release from basal forebrain cholinergic neurons may result in less feedback 
inhibition through M2 receptors, and more glutamate being co-released. 
 Thus, I predict that, decreasing cholinergic tone may trigger the glutamatergic 
neurons to increase their activity or enhance the release of glutamate from basal forebrain 
cholinergic neurons.  In agreement with this, NMDA receptor antagonist CPP abolished 
the awake-immobility theta in VAChT KDHET mice, and not other groups of mice. In 
contrast, immobility theta in wildtype and VAChTNkx2.1-Cre-flox/flox mice was not 
significantly affected after CPP injection. Other than expecting to block glutamatergic 
NMDA receptor-mediated synaptic transmission in the hippocampus, CPP is expected to 
block NMDA receptors mediated by septo-hippocampal glutamatergic neurons synapsing 
on both hippocampal and medial septal neurons, and glutamatergic neurons projecting 
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from SUM directly to the hippocampus (Kiss et al., 2000) and indirectly to the medial 
septum (Vertes, 1992; Borhegyi et al., 1998). The nature of compensation that may have 
happened in these SUM, septohippocampal, or hippocampal glutamatergic neurons 
remains to be studied.  
4.2   Hippocampal activation during walking 
Theta power during walking did not show a significant difference among the 
different VAChT mutants, suggesting that the amplitude of walking-induced theta might 
be mainly mediated by non-cholinergic neurons. GABAergic (Stewart and Fox, 1990; 
Yoder and Pang, 2005; Simon et al., 2006, Borhegyi et al., 2006) and glutamatergic 
(Leung and Desborough, 1988; Leung and Shen, 2004) septo-hippocampal inputs may 
maintain the theta rhythmicity during voluntary movements. In addition to septo-
hippocampal inputs, serotonin may mediate walking induced theta (Vanderwolf, 1988).  
My study showed a decrease in walking-induced theta power following 
scopolamine injection in Wild-Type and VAChT KDHET mice but not in VAChTNkx2.1-Cre-
flox/flox
 mice. This result supports the proposal that an atropine-sensitive component is also 
found in the hippocampal theta rhythm during walking in the wildtype and VAChT 
KDHET mice (Shin et al., 2005), similar to rats (Vanderwolf, 1988; Leung, 1998; Bland 
and Oddie, 2001). In a study by Leung (1985), the rise of the theta peak recorded during 
walking was reduced after atropine. On the other hand, the lack of atropine sensitivity of 
the walking theta in VAChTNkx2.1-Cre-flox/flox mice may be expected for mice without 
acetylcholine release in the septohippocampal neurons, and brainstem cholinergic inputs 
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to the medial septum were apparently not participating in atropine sensitivity during 
walking. 
Power of theta rhythm during walking was suppressed in all groups of mice after 
injection of CPP, suggesting that glutamate and NMDA receptors have a critical role in 
the generation of walking induced theta. Injection of NMDA receptor antagonist D-2-
amino-5-phosphonovaleric acid (D-APV) directly to the medial septum suppressed the 
amplitude of theta significantly (Leung and Shen, 2004). No such reduction was noticed 
by injection of AMPA receptors antagonist (DNQX) suggesting postsynaptic NMDA 
receptors in the medial septum control the amplitude of the hippocampal theta rhythm 
(Leung and Shen, 2004). Other than medial septum, theta recorded in CA1 is partially 
driven by distal-dendritic excitation of the pyramidal cells by the perforant pathway from 
the entorhinal cortex (Vanderwolf and Leung, 1983; Leung, 1984). This pathway is 
mediated by both NMDA and AMPA receptors (Colbert and Levy, 1992) and 
inactivation of this pathway strongly attenuated theta rhythm (Heynan and Bilkey, 1994). 
Furthermore, the independent pacemaker in the CA3 (Kocsis et al., 1999), activated by 
septohippocampal cholinergic neurons, also have a role in generation of theta in CA1 
region. APV blocked the theta rhythm induced by cholinergic agonists in CA3 in vitro 
(Fellous and Sejnowski, 2000). 
There may be several reasons why atropine-resistant theta was not totally 
abolished after CPP injection. First, cholinergic, atropine-sensitive component also drives 
or facilitates theta during walking (Vanderwolf, 1988; Leung, 1998; Bland and Oddie, 
2001). Second, only the NMDA component of normal glutamatergic transmission is 
blocked, and the non-NMDA component remains intact. In addition, glutamate may only 
64 
 
be one of the more important neurotransmitter mediating the atropine-resistant theta, and 
other neurotransmitters such as GABA and serotonin may also play a role in generation 
of the theta rhythm during walking. The medial septum projects GABAergic neurons to 
the hippocampus. GABA released from these neurons attaches to the GABA-A receptors 
located postsynaptically on the interneurons. Medial septal injection of muscimol, a 
GABA-A receptor agonist also attenuated the hippocampal theta amplitude (Bland et al., 
1996). Serotonin depletion via selective lesion of median raphe neurons or sectioning of 
presumed 5-HT pathway to the hippocampus strongly attenuated the power of walking 
induced theta (Vanderwolf, 1988). 
In all three groups of mice studied here, the peak of the theta rhythm shifted to a 
significantly lower frequency after injection of CPP, while no such effect was observed 
after administration of scopolamine. Kirk (1998) suggested that the frequency of the theta 
rhythm is coded downstream to the medial septum, presumably in the SUM. MS-DBB 
receives phasic information from SUM, the frequency of which determines the frequency 
of septal bursting and that of hippocampal theta (Kirk, 1998). SUM acts as the 
intensity/frequency transducer (Kirk, 1998). SUM receives many inputs from the 
brainstem that are glutamatergic (Kiss et al., 2002). The reduction of theta frequency after 
CPP might be due to the fact that the NMDA component of these glutamatergic pathways 
has been disrupted. Theta peak frequency of VAChT KDHET mice was significantly 
higher than Wild-Type and VAChTNkx2.1-Cre-flox/flox mice which might have resulted from 
higher glutamatergic release in the SUM or medial septum, as a consequence of low 
cholinergic presynaptic inhibition (Allen et al., 2006), or as a consequence of 
compensation during development.  
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Administration of CPP severely impaired voluntary movement in all three groups, 
as has been observed after other NMDA receptor antagonists (Leung and Shen, 2004). 
Mice showed difficulty maintaining balance, moving hind limbs, standing and jumping. 
These symptoms started to appear almost 45 minutes post injection and they recovered a 
few hours later. Walking data included in the analysis of my results in the thesis were all 
recorded before the onset of these symptoms.  
4.3   Gamma oscillations 
Gamma activity is proposed to be generated by a recurrent inhibition circuit 
involving pyramidal cells and GABAergic interneurons (Leung, 1982, 1998; Mann et al., 
2005), and brainstem input is suggested to increase recurrent inhibitory gain and increase 
gamma oscillations (Leung, 1982). Power of gamma increased during walking as 
compared to immobility in mice. The increase of low-frequency (30-70 Hz) gamma 
power was significant in the two mutant mouse lines but not in Wild-Type mice. High-
frequency (70-100 Hz) gamma power increased significantly in all three groups during 
walking. Stumpf (1965b) showed that 0.75 mg/kg (they did not say i.p. or i.v., but it is 
common to inject rabbits i.v.) scopolamine did not prevent the evocation of hippocampal 
gamma activity evoked by brainstem stimulation in immobilized unanesthetized rabbits. 
In contrast to Stumpf, Leung (1985) reported that atropine caused a decrease in gamma 
activity in rats. My results indicated that scopolamine failed to change the power of 
gamma oscillations significantly. This observation was consistent for all three groups of 
mice both during walking and awake-immobility. My results showed that injection of the 
NMDA receptor glutamatergic antagonist CPP, failed to change the power of low- and 
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high-frequency gamma oscillation during awake-immobility and walking with the 
exception of power of low-frequency gamma of VAChTNkx2.1-Cre-flox/flox mice during 
walking. This is consistent with the finding that AMPA receptor, but not NMDA 
blockade, in the hippocampus attenuated hippocampal gamma rhythm (Leung and Shen, 
2004).  
4.4   Limitations and future studies 
While electrophysiology of the hippocampus of these two mutant mouse lines was 
studied during walking and awake-immobility, I did not study the hippocampal activation 
of these mice during sleep. LFPs recorded in this study were limited to the CA1 region of 
the hippocampus while it is important to record LFPs from other brain regions such as the 
neocortex. Efforts were made to select the best LFPs for each type of behavior; however, 
simultaneous video-LFP recording will significantly reduce the chance of errors made in 
this selection. Another major limitation in my study was proper placement of the 
electrodes as brain size varies from mouse to mouse. Using multi-channel electrodes will 
significantly increase the chance of placing electrodes into specific layer of the 
hippocampus, as well as provide laminar profiles of the LFPs. Cholinesterase inhibitor 
drugs such as galantamine are among the most common types of drugs used in 
controlling patients with AD. Since VAChT and acetylcholine deficient mice are models 
for AD, it is important to study the effects of these drugs on LFPs and behavior.  
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4.5   Conclusion 
The availability of VAChT KDHET and VAChTNkx2.1-Cre-flox/flox mutant mouse lines 
displaying different levels of VAChT expression provides us with the unique opportunity 
to evaluate the consequences of reduced VAChT levels for brain functions. Multiple 
behavioral deficits such as social and object recognition, spatial memory, attention in the 
5 choice serial reaction task and hyperactivity were observed in these genetically 
modified mice (Prado et al., 2006; Martin-Silva et al., 2011; Martyn et al., 2012: Al-
Onaizi et al., under review). The primary goal of this study was to use electrophysiology 
to record LFPs from the hippocampus of these two mutant mouse lines in order to further 
define the role of VAChT and ACh release on hippocampal activation during awake-
immobility and walking. The main findings of the present experiments are that (1) 
VAChT expression and ACh release are necessary for generation of hippocampal theta 
rhythm during awake-immobility, (2) generation of hippocampal theta rhythm during 
walking involved non-cholinergic neurotransmitters., although ACh was also involved 
(Leung, 1998); (3) gamma power in the hippocampus of VAChT KDHET and 
VAChTNkx2.1-Cre-flox/flox mice was not significantly different from that in Wild-Type mice, 
suggesting cholinergic neurons have little impact on generation of hippocampal gamma 
oscillations; (4) immobile theta in VAChTNkx2.1-Cre-flox/flox and Wild-Type mice was 
sensitive to scopolamine, while VAChT KDHET mice was not. Furthermore, VAChT 
KDHET mice, as compared to Wild-Type mice, manifested higher peak theta frequency 
during walking. Cholinergic afferents from brainstem to septum may be compensated by 
non-cholinergic brainstem-septal synapses in VAChT KDHET mice. 
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